Abstract:Objective To explore and to determined the optima conditions for refolding of the prokaryotic 6B11ScFv/mHSP70 fusion protein in vitro.Methods To express the recombinant 6B11ScFv/mHSP70 fusion protein by the prokaryotic expression system E.coli:① To compare the efficiency of 8 mol/L urea and 6 mol/L guanidine hydrochloride in solution of the inclusion body;② To examine the effects of sequential dilution method, presence of different redox system and diverse L-arginine concentration on protein aggregation and activity during the refolding process;③ To investigate the value of dilution refolding and on-column refolding in the recovery of active 6B11ScFv/mHSP70 protein.The concentrations of protein in both inclusion body lysate and refolding buffers were determined by Bradford method.We evaluate the activity of this fusion protein to combine with specific antibody by ELISA.Results The recombinant proteins were expressed in the form of inclusion body in E.coli BL21(DE3):① The solution efficiency of 6 mol/L guanidine hydrochloride was much higher than that of 8 mol/L urea.But the former protein activity after refolding was poorer than the latter.To dissolve the inclusion body in 6 mol/L guanidine hydrochloride and then dialyze with 8 mol/L urea before the refolding process exhibits excellent efficiency and protein activity;② The sequential dilution procedure and the addition of 0.5 mol/L L-arginine could effectively reduce protein aggregation in the dilution process.The addition(GSH:GSSH = 1:5) may facilitate refolding but not suppress aggregation;③ The on-column refolding could achieve both recovery and purification of the protein in a single procedure but with lower refolding efficiency and poorer activity than dilution refolding for this protein.Conclusions We establish the optimal solution and refolding conditions for the 6B11ScFv/mHSP70 fusion protein.The inclusion body of the fusion protein was dissolved thoroughly in 6 mol/L guanidine hydrochloride, and then dialyzed with 8 mol/L urea.The dissolved extracts were refolding in buffers with 0.5 mol/L L-arginine and GSH:GSSH = 1:5 by sequential dilution.And the refolding protein shows satisfactory immunoactivity and could be used in further research of protein functions.

L-arginine suppresses aggregation of recombinant growth hormones in refolding process from E. coli inclusion bodies

Refolding of recombinant human interferon-gamma by expanded bed adsorption chromatography with urea gradient

Different effects of L-arginine on protein refolding: suppressing aggregates of hydrophobic interaction, not covalent binding.

Cooperative effects of urea and L-arginine on protein refolding.

A newly proposed mechanism for arginine-assisted protein refolding--not inhibiting soluble oligomers although promoting a correct structure.

Refolding and two-step purification by hydrophobic interaction chromatography of recombinant human bone morphogenetic protein-2 from Escherichia coli

Mammalian perfusion cultivation at high L-Arginine concentration for efficient production of recombinant protein by increasing perfusion filter transmission

Arginine as a regulator of antioxidant and gel formation in yak Myofibrillar proteins: Efficacy and mechanistic insights

A novel protein refolding system using lauroyl-l-glutamate as a solubilizing detergent and arginine as a folding assisting agent

Overexpression and Purification of Recombinant Atrial Natriuretic Peptide Using Hybrid Fusion Protein REF-ANP in Escherichia Coli

Cultivation to improve in vivo solubility of overexpressed arginine deiminases in Escherichia coli and the enzyme characteristics

Enzymatic Synthesis of Agmatine by Immobilized Escherichia Coli Cells with Arginine Decarboxylase Activity

Highly Efficient Production of Soluble Proteins from Insoluble Inclusion Bodies by a Two-Step-denaturing and Refolding Method.

Dietary L-arginine Levels Affect the Liver Protein Turnover and Alter the Expression of Genes Related to Protein Synthesis and Proteolysis of Laying Hens.

Effects of Dietary L-arginine Levels on Small Intestine Protein Turnover and the Expression of Genes Related to Protein Synthesis and Proteolysis of Layers

Refolding single-chain antibody (scFv) using lauroyl-L-glutamate as a solubilization detergent and arginine as a refolding additive

Purification of inclusion bodies using PEG precipitation under denaturing conditions to produce recombinant therapeutic proteins from Escherichia coli

Human growth hormone inclusion bodies present native-like secondary and tertiary structures which can be preserved by mild solubilization for refolding

Refolding of the ovarian anti-idiotypic single chain antibody 6B11ScFv and mouse HSP70 fusion protein expressed by E.coli

Improved method for expression and isolation of the Mycoplasma hominis arginine deiminase from the recombinant strain of Escherichia coli

Efficient and easily scalable protein folding strong anion exchange chromatography for renaturation and simultaneous purification of recombinant human asparaginase from E. coli